Pontifax Management 4 G.P. (2015) Ltd. Insider Trading
Get free email notifications about insider trading for Pontifax Management 4 G.P. (2015) Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Pontifax Management 4 G.P. (2015) Ltd.. Pontifax Management 4 G.P. (2015) Ltd. is a in Eloxx Pharmaceuticals, Inc. ($ELOX) and a 10% Owner in Eloxx Pharmaceuticals, Inc. ($ELOX) and a 10% Owner in Keros Therapeutics, Inc. ($KROS).
Address: C/O ELOXX PHARMACEUTICALS, INC. 950 WINTER STREET, 4TH FLOOR NORTH WALTHAM 02451 MA
Companies in which Pontifax Management 4 G.P. (2015) Ltd. is an Insider
Eloxx Pharmaceuticals, Inc.
Trading Symbol: ELOXIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Pontifax Management 4 G.P. (2015) Ltd.: 10% Owner
Holdings: 1,791,470 shares
Current Value: $412,038
Latest Transaction: May 17 2021
$ELOX Market Capitalization: $4.75M
$ELOX Previous Close: $0.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Keros Therapeutics, Inc.
Trading Symbol: KROSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Pontifax Management 4 G.P. (2015) Ltd.: 10% Owner
Holdings: 2,288,151 shares
Latest Transaction: Nov 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Pontifax Management 4 G.P. (2015) Ltd.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 1.35 | 592,592 | 799,999 | 616,592 | 24 K to 616.6 K (+2,469.13 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 1.35 | 1,422,222 | 1,920,000 | 1,989,551 | 567.3 K to 2 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 1.35 | 2,630,487 | 3,551,157 | 3,679,797 | 1 M to 3.7 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 1.35 | 1,280,624 | 1,728,842 | 1,791,470 | 510.8 K to 1.8 M (+250.69 %) |
Nov 19 2020 | KROS | Keros Therapeutics ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 50.00 | 6,000 | 300,000 | 155,262 | 149.3 K to 155.3 K (+4.02 %) |
Nov 19 2020 | KROS | Keros Therapeutics ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 50.00 | 14,400 | 720,000 | 1,228,326 | 1.2 M to 1.2 M (+1.19 %) |
Nov 19 2020 | KROS | Keros Therapeutics ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 50.00 | 12,966 | 648,300 | 1,122,768 | 1.1 M to 1.1 M (+1.17 %) |
View all Pontifax Management 4 G.P. (2015) Ltd. insider transactions.